EY Life Sciences

Key themes from “The Next Frontiers in

Precision Medicine” panel

February 2016
Evolution of precision medicine

One-size-fits-all Precision
therapeutics medicine

Convergence of
Tx, Dx and
Disconnected Connected consumer creating
health care health care new vision of the
super health care
consumer

Sick-care Well-care

Page 2 Presentation title

The next frontiers in precision medicine:
key themes

1
Convergence of therapeutics, diagnostics and consumerism in
the life sciences industry is here to stay.

2 Development of creative commercial strategy and

M&A strategy is imperative to drive success.

3 The scientific and clinical underpinnings of these

convergence plays drive their real value.

4
Strong diligence must be performed to be sure to cut
through all of the hype and choose the real winners in
the space.

Page 3
EY Life Sciences
We work with a broad spectrum of life sciences companies to meet business needs,
from strategy to deal execution.

Our professionals have deep clinical, scientific

and consulting experience in the following
areas:

Pharma and Medical Life science Information

Diagnostics
biotech device tools technology
► R&D ► In vitro ► Cardiovascular ► Cell biology ► Health IT
► Drug delivery ► Anatomical path ► GI/urology ► Laboratory animals ► Bioinformatics
► Marketing/brand ► Clinical chem ► Hospital supplies ► Mass spec ► Data analytics
management ► Immunoassay ► Imaging ► Microarray ► Data management
► Medical advisory ► Microbiology ► Neurology ► Microscopy and storage
► Commercial ► Molecular ► Orthopedics ► PCR
► LIMS
► LCM ► Point-of-care ► Patient monitoring ► Proteomics
► Algorithm
► Managed markets development
► In vivo ► Respiratory ► Sample prep
► Specialty pharma
► App
► Reference/specialty ► Surgical equipment ► Separations
development
► Distribution labs ► Wound care ► Sequencing ► Connected
health
Disease areas

Cardiovascular CNS Dermatology Endocrinology GI Hematology Immunology

Infectious disease Nephrology Obesity Oncology Ophthalmology Orphan Orthopedics

Pain Psychiatry Respiratory Rheumatology Urology Vaccines Women’s health

Page 4
Key contacts

Kristin Ciriello Pothier John L. Babitt

Head of Life Sciences, Parthenon-EY
Transaction Advisory Services
Ernst & Young LLP
+1 617 549 2779
kristin.pothier@ey.com
Life Sciences Financial Diligence
and Medtech Leader Transaction
Advisory Services, Ernst & Young
LLP
+1 212 773 0912
john.babitt@ey.com

Scott Palmer Mahala Burn

Precision Medicine Leader, Parthenon-EY Life Sciences Practice Director, Parthenon-EY
Transactions Advisory Services Transaction Advisory Services,
Ernst & Young LLP Ernst & Young LLP
+1 415 894 8863 +1 617 478 7023
scott.palmer@ey.com mahala.burn@parthenon.ey.com

Page 5
EY | Assurance | Tax | Transactions | Advisory
About EY
EY is a global leader in assurance, tax, transaction and advisory services.
The insights and quality services we deliver help build trust and confidence
in the capital markets and in economies the world over. We develop
outstanding leaders who team to deliver on our promises to all of our
stakeholders. In so doing, we play a critical role in building a better
working world for our people, for our clients and for our communities.

EY refers to the global organization and may refer to one or more of the
member firms of Ernst & Young Global Limited, each of which is a separate
legal entity. Ernst & Young Global Limited, a UK company limited by
guarantee, does not provide services to clients. For more information about
our organization, please visit ey.com.

Ernst & Young LLP is a client-serving member firm of Ernst & Young
Global Limited operating in the US.

© 2016 Ernst & Young LLP.

All Rights Reserved.

ED None

This material has been prepared for general informational purposes only
and is not intended to be relied upon as accounting, tax or other
professional advice. Please refer to your advisors for specific advice.

ey.com